Hypoglycemic capsules containing seven ingredients with rehmannia

Abstract

The invention provides a seven-medicine glutinous rehmannia sugar reduction capsule, which consists of the following materials in portion by weight: 60 to 70g of dried rehmannia root, 60 to 70g of raw Chinese yam, 60 to 70g of Tuckahoe, 60 to 70g of oriental water plantain, 35 to 45g of pulp of dogwood fruit, 35 to 45g of root of red-rooted salvia and 8 to 12g of cinnamon. The preparation method comprises the following steps: according to the weight portion and the addition ratio, the dried rehmannia root, the raw Chinese yam, the Tuckahoe, the oriental water plantain, the pulp of dogwood fruit, the root of red-rooted salvia and the cinnamon are crushed into fine powder, sieved, evenly mixed and capsulated to prepare the seven-medicine glutinous rehmannia sugar reduction capsule. The seven-medicine glutinous rehmannia sugar reduction capsule has the efficacies of supplementing qi, nourishing yin, promoting production of body fulid and quenching thirst, is applicable for a diabetic patient accompanied with high blood fat, high blood pressure and retinopathy, and has the advantages of good treatment effect, no side effect and low production cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a Qiwei Dihuang hypoglycemic capsule. technical background [0002] Diabetes is one of the most common chronic diseases. With the improvement of people's living standards, the aging population and the increase in the incidence of obesity, the incidence of diabetes is increasing year by year. Hyperglycemia is the main clinical sign. Type II diabetes, formerly known as non-insulin-dependent diabetes, accounts for about 90% of the total number of diabetic patients, and more than 90% of type II diabetic patients are accompanied by hyperlipidemia, hypertension, overweight and obesity It is one of the main risk factors of type 2 diabetes. Some patients with type 2 diabetes are also accompanied by retinopathy. The existing treatment drugs are mostly western medicines, most of which only have hypoglycemic effects, have no effect on complications, and are prone to hypoglycemi...

AI Technical Summary

Problems solved by technology

Hyperglycemia is the main clinical sign. Type II diabetes, formerly known as non-insulin-dependent diabetes, accounts for about 90% of the total number of diabetic patients, and more than 90% of type II diabetic patients are accompanied by hyperlipidemia, hypertension, overweight and obesity It is one of the main risk factors of type 2 diabetes. Some patients with type 2 diabetes are also accompanied by retinopathy. The existing treatment drugs are mostly western medicines, most of which only have hypoglycemic effects, have no effect on complications, and are prone to hypoglycemia , side effects are large, not suitable for long-term use